SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea
· Delayed Price · Currency is KRW 90,400
-7,500 (-7.66%)
At close: May 9, 2025, 3:30 PM KST
SK Biopharmaceuticals Market Cap
SK Biopharmaceuticals has a market cap or net worth of 7.08 trillion as of May 9, 2025. Its market cap has increased by 1.46% in one year.
Market Cap
7.08T
Enterprise Value
6.97T
Revenue
547.60B
Ranking
n/a
PE Ratio
29.41
Stock Price
90,400.00
Market Cap Chart
Since July 2, 2020, SK Biopharmaceuticals's market cap has decreased from 9.95T to 7.08T, a decrease of -28.82%. That is a compound annual growth rate of -6.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 7,079.52B | -18.63% |
| Dec 30, 2024 | 8,700.60B | 10.66% |
| Dec 28, 2023 | 7,862.65B | 39.25% |
| Dec 29, 2022 | 5,646.39B | -25.82% |
| Dec 30, 2021 | 7,612.05B | -42.49% |
| Dec 30, 2020 | 13.23T | 33.07% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 77.22T |
| Celltrion | 34.62T |
| ALTEOGEN | 19.00T |
| Yuhan | 8,496.01B |
| HLB Co., Ltd. | 7,528.95B |
| PharmaResearch | 4,046.77B |
| Peptron | 3,967.54B |
| LigaChem Biosciences | 3,925.71B |